BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3142783)

  • 1. Differentiation of U937 cells induced by 5,8,11,14-eicosatetraynoic acid, a competitive inhibitor of arachidonic acid metabolism.
    Ondrey F; Anderson K; Hoeltgen D; Harris J
    Exp Cell Res; 1988 Dec; 179(2):477-87. PubMed ID: 3142783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4.
    Ondrey F; Harris JE; Anderson KM
    Cancer Res; 1989 Mar; 49(5):1138-42. PubMed ID: 2492901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5,8,11,14-eicosatetraynoic acid-induced differentiation of U937 cells.
    Anderson KM; Ondrey FG; Harris JE
    Ann Clin Lab Sci; 1989; 19(2):92-100. PubMed ID: 2751242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human PC-3 prostate cell line DNA synthesis is suppressed by eicosatetraynoic acid, an in vitro inhibitor of arachidonic acid metabolism.
    Anderson KM; Wygodny JB; Ondrey F; Harris J
    Prostate; 1988; 12(1):3-12. PubMed ID: 2831523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETYA, a pleotropic membrane-active arachidonic acid analogue affects multiple signal transduction pathways in cultured transformed mammalian cells.
    Anderson KM; Ondrey F; Harris JE
    Clin Biochem; 1992 Feb; 25(1):1-9. PubMed ID: 1551235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inhibitor of arachidonic acid metabolism stimulates luteinizing hormone (LH) release from cultured pituitary cells.
    Conn PM; Whorton R; Lazar J
    Prostaglandins; 1980 Jun; 19(6):873-9. PubMed ID: 6770421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of 5,8,11,14-eicosatetraynoic acid (ETYA) into cell lipids: competition with arachidonic acid for esterification.
    Taylor AS; Morrison AR; Russell JH
    Prostaglandins; 1985 Mar; 29(3):449-58. PubMed ID: 3923563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eicosatetraynoic and arachidonic acid-induced changes in cell membrane fluidity consonant with differences in computer-aided design-structures.
    Brown M; Anderson KM; Patel H; Hopfinger AJ; Harris JE
    Biochim Biophys Acta; 1992 Apr; 1105(2):285-90. PubMed ID: 1586665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cytotoxic T lymphocyte-mediated lysis by ETYA: effect independent of arachidonic acid metabolism.
    Taylor AS; Howe RC; Morrison AR; Sprecher H; Russell JH
    J Immunol; 1985 Feb; 134(2):1130-5. PubMed ID: 2981259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5,8,11,14-eicosatetraynoic acid-induced destruction of mitochondria in human prostate cells (PC-3).
    Anderson KM; Seed TM; Wilson DE; Harris JE
    In Vitro Cell Dev Biol; 1992 Jun; 28A(6):410-4. PubMed ID: 1634441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of ETYA, a PUFA-analogue, on prostate (PC3) and monoblastoid U937 ultrastructure; lack of correlation with reduced proliferation.
    Anderson KM; Seed TM; Harris JE
    Prostaglandins Leukot Essent Fatty Acids; 1992 Feb; 45(2):151-7. PubMed ID: 1561235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5,8,11,14-eicosatetraynoic acid inhibits PC3 DNA synthesis and cellular proliferation, in part due to its 5'-lipoxygenase activity.
    Anderson KM; Harris JE
    Clin Physiol Biochem; 1990; 8(6):308-13. PubMed ID: 2132166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid metabolism and modulation of in vitro anaphylaxis by 5,8,11,14-eicosatetraynoic acid and 9a,12a-octadecadiynoic acid.
    Hitchcock M; Kokolis NA
    Br J Pharmacol; 1981 Apr; 72(4):689-95. PubMed ID: 6793116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-accelerated phospholipid metabolism by 5,8,11,14-eicosatetraynoic acid.
    Wertz PW; Mueller GC
    Cancer Res; 1980 Mar; 40(3):776-81. PubMed ID: 7008936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid analogues: an additional class of membrane--active agents with potential anticancer activity.
    Anderson KM; Ondrey F; Harris JE
    Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(4):231-41. PubMed ID: 2654962
    [No Abstract]   [Full Text] [Related]  

  • 16. Arachidonic acid metabolism in isolated pancreatic islets. II. The effects of glucose and of inhibitors of arachidonate metabolism on insulin secretion and metabolite synthesis.
    Turk J; Colca JR; Kotagal N; McDaniel ML
    Biochim Biophys Acta; 1984 Jun; 794(1):125-36. PubMed ID: 6428455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of 5,8,11,14-eicosatetraynoic acid on lipid metabolism.
    Tobias LD; Hamilton JG
    Lipids; 1979 Feb; 14(2):181-93. PubMed ID: 106197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced drug resistance in a multidrug resistant cell line by 5,8,11,14-eicosatetraynoic acid.
    Anderson KM; Harris JE
    Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):195-203. PubMed ID: 7881868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylene blue and ETYA block flow-dependent dilation in canine femoral artery.
    Kaiser L; Hull SS; Sparks HV
    Am J Physiol; 1986 Jun; 250(6 Pt 2):H974-81. PubMed ID: 3013027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ETYA and BW 755c on arachidonate-induced contractions in the guinea-pig isolated trachea.
    Mitchell HW
    Br J Pharmacol; 1982 Aug; 76(4):527-9. PubMed ID: 6809090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.